January 26, 2015 11:30 PM ET

Healthcare Equipment and Supplies

Company Overview of Boston Heart Diagnostics Corporation

Company Overview

Boston Heart Diagnostics Corporation develops lipid tests and methodologies for cardiovascular risk assessment and disease management. The company offers integrated diagnostics, personalized reporting, and lifestyle management solutions that enable healthcare providers and patients to improve heart health and prevent disease. Its solutions include Boston Heart HDL Map, a test that quantifies the amount of apoA-I in the five most significant subpopulations, resulting in an understanding of a patient’s cardiovascular disease (CVD) risk; Boston Heart Cholesterol Balance Test, a test that directly measures the production and absorption markers for circulating plasma cholesterol; Boston Heart Sta...

175 Crossing Boulevard

Suite 100

Framingham, MA 01702

United States

Founded in 2007

Phone:

508-877-8710

Fax:

508-877-8707

Key Executives for Boston Heart Diagnostics Corporation

Chief Executive Officer
Age: 56
Chief Financial Officer
Senior Vice President of Operations
Compensation as of Fiscal Year 2014.

Boston Heart Diagnostics Corporation Key Developments

Boston Heart Cardiovascular Diagnostics and Services Earn Coverage Agreement from a National Health Insurer

Boston Heart announced that it has entered into a national agreement with a health insurance company that is dedicated to helping people improve their health, well-being and sense of security, to provide in-network advanced diagnostic testing. Effective January 1, 2015, this agreement will expand access of Boston Heart testing, personalized reporting, and health literacy tools to the insurer's 13 million, largely self-insured employer members throughout the United States.

Boston Heart Diagnostics Corporation Launches FDA-Cleared MPO (Myeloperoxidase) Test

Boston Heart Diagnostics Corporation announced the commercial launch of an FDA-cleared MPO (myeloperoxidase) test, a key biomarker for inflammation. Studies show that MPO levels are useful predictors of near-term (one to six months) risk of heart attack or stroke. The launch of MPO is an important addition to the suite of next-generation diagnostics the company already offers. More than lab results, Boston Heart gives healthcare providers the tools they need to identify risk, individualize treatment plans, and engage patients in preventing and reversing cardiovascular disease. Boston Heart offers the MPO test as an individual assay, or as part of a panel of other critical inflammation markers including hs-CRP and LpPLA. Unlike other MPO assays on the market, the Boston Heart MPO test does not require a separate sample tube, nor do office staff need to spend time aliquoting. Patients may benefit from having fewer tubes of blood drawn, and the risk of specimen rejection and redraw may be reduced, since aliquoting can be a cause of insufficient sample.

Boston Heart Diagnostics Corporation Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 03:00 PM

Boston Heart Diagnostics Corporation Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 03:00 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Susan Hertzberg, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Bilt-Rite Orthopedics & Safety, Inc. United States
Intellison United States
Medivators Inc. United States
QBC Diagnostics, Inc. United States
MedaCheck LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 8, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Boston Heart Diagnostics Corporation, please visit www.bostonheartdiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.